FULC FY 2019 Earnings — Fulcrum Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FULCFulcrum Therapeutics, Inc.

$411M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2M

Operating Income

-$59M

Net Income

-$83M

EPS (Diluted)

$-3.49

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$110M

Total Liabilities

$23M

Stockholders' Equity

$87M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2M	-$1M	-52.6%
Operating Income	-$59M	-$33M	-75.0%
Net Income	-$83M	-$33M	-153.7%